Harvest Integrated Research Organization (HiRO) has announced the completion of its Series A financing in the tens of mi...
Lynk Pharmaceuticals and Simcere announced a strategic partnership to develop and commercialize a highly selective JAK1 ...
SyMap Medical is developing a selective map-and-ablate technology that has the potential to substantially improve outcom...
Ping An Healthcare and Technology Company Limited (Ping An Good Doctor) has announced its 2021 annual results. During th...
Clarivate Plc, a global leader in providing trusted information and insights to accelerate the pace of innovation, ...
Adlai Nortye Ltd., a clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies,...
MediLink Therapeutics (Suzhou) Co., Ltd (MediLink) has announced completion of a $70million Series B financing. Thi...
GenieBiome (G-NiiB), a biotechnology spin-off of The Chinese University of Hong Kong (CUHK), announces the launch of G-N...
Hong Kong Baptist University (HKBU) has established a transdisciplinary team of experts and supporting personnel to...
Eucure Biopharma, a wholly owned subsidiary of Biocytogen, announced the first patient dosing for a phase I multi-r...
IMPACT Therapeutics, a biopharmaceutical company dedicated to the discovery and development of targeted anti-cancer ther...
Asieris Pharmaceuticals, a global innovative biopharma company specializing in discovering and developing innovativ...
Pulnovo Medical Limited, a globally recognized OTM innovative platform, recently announced the appointment of Jessie Lia...
Chinese firm Gan & Lee Pharmaceuticals has announced that the first subject has been dosed in our Phase I, double-bl...
The MIKADO group, a translational team at the University of Zurich (UZH) focused on generating evidence-driven...
Researchers from the School of Public Health, LKS Faculty of Medicine of The University of Hong Kong (HKUMed), in collab...
SeekIn Inc, the leader in blood-based cancer early detection and monitoring technology, has announced the CE (Conformit&...
Akeso, Inc., a biopharmaceutical company dedicated to the development of innovative antibody drugs, has announced that t...
